Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Stephen Davis


  • Ceo at Acadia Pharmaceuticals Inc (ACAD), 2019-10-17
  • Director at Heron Therapeutics Inc. (HRTX), 2019-10-02
  • Director at Bellicum Pharmaceuticals Inc (BLCM), 2019-06-14
  • Director at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Director at Furiex Pharmaceuticals Inc. (FURX), 2014-07-07
  • Evp & Coo at Ardea Biosciences Inc. (RDEA), 2012-06-20
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACAD $39.65 2,983 Officer, Director 2,954 2019-10-15 Filing
ACAD $40.19 120,208 Officer, Director 0 2019-10-10 Filing
ACAD $40.00 29,792 Officer, Director 0 2019-10-09 Filing
RDEA $15.91 700 Officer 16,222 2012-01-06 Filing
RDEA $18.86 432 Officer 17,331 2011-11-15 Filing